Altimmune (ALT) Depreciation and Depletion (2012 - 2026)
Altimmune's (ALT) quarterly Depreciation and Depletion came in at $23000.0 in Q1 2026, down 20.69% year-on-year from $29000.0 in Q1 2025, and down 11.54% on a QoQ basis from $26000.0 in Q4 2025.
Altimmune (ALT) Depreciation and Depletion (2012 - 2026) Analysis & Trends
Altimmune (ALT) has 15 years of Depreciation and Depletion data on file, last reported at $23000.0 in Q1 2026.
- On a quarterly basis, Depreciation and Depletion fell 20.69% year-over-year to $23000.0 in Q1 2026; TTM through Mar 2026 was $106000.0, a 13.11% decrease from a year earlier, with the FY2025 full-year figure at $112000.0, down 44.0% from the prior year.
- Depreciation and Depletion for Q1 2026 stood at $23000.0, down from $26000.0 in the prior quarter.
- Over the last five years, Depreciation and Depletion for ALT reached as high as $137000.0 in Q4 2023 and fell as low as -$5000.0 in Q4 2024.
- Historically, Depreciation and Depletion has averaged $66785.7 across 5 years, with a median of $49000.0 in 2024.
- Across the five-year window, Depreciation and Depletion sank 103.65% in 2024 and soared 620.0% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $100000.0 in 2022, then surged by 37.0% to $137000.0 in 2023, then sank by 103.65% to -$5000.0 in 2024, then surged by 620.0% to $26000.0 in 2025, then decreased by 11.54% to $23000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation and Depletion figures were $23000.0 in Q1 2026, $26000.0 in Q4 2025, and $27000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23,000.00 |
| Mar 31, 2026 | 23,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 30,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 61,000.00 |
| Mar 31, 2024 | 107,000.00 |
| Mar 31, 2024 | 107,000.00 |
| Dec 31, 2023 | 137,000.00 |
| Dec 31, 2023 | 137,000.00 |